AGRX News and Press, Agile Therapeutics Inc. From 11/08/23

2023-11-08 10:38:30 ET Major earnings expected before the bell on Thursday include: AstraZeneca ( AZN ) Fiverr International ( FVRR ) Li Auto ( LI ) Novavax ( NVAX ) Petróleo Brasileiro S.A. ( PBR ) For further details see: Nota...

Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report third quarter 2023 financial results before the market open on Thursday, November ...

PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the granting of a previously disclosed inducement award to the Company’s newly appointed Chief Financial Officer, Scott Coiante. In accordance wi...

2023-09-28 16:19:48 ET Shares of Agile Therapeutics (NASDAQ: AGRX) were up more than 23% for the week as of 3 p.m. on Thursday, according to data provided by S&P Global Market Intelligence . The women's healthcare company's shares closed last week at $1.76, then rose to ...

PRINCETON, NJ / ACCESSWIRE / September 28, 2023 / Maxim Group , a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its research. The firm's focus and area of expertise is in s...

2023-09-22 09:59:56 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecuti...

PRINCETON, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairperson and Chief Executive Officer Al Altomari and Chief Commercial Officer Amy Welsh will present at the H.C. Wainwright 25 th Annual Global In...

PRINCETON, NJ / ACCESSWIRE / August 17, 2023 / On August 9, Agile Therapeutics (NASDAQ:AGRX) released its second-quarter financial results, showing significant growth in revenue from its innovative weekly birth control patch, Twirla® (levonorgestrel and ethinyl estradiol), and a wid...

2023-08-09 12:33:05 ET Start Time: 08:30 End Time: 09:06 Agile Therapeutics, Inc. (AGRX) Q2 2023 Earnings Conference Call August 09, 2023, 08:30 AM ET Company Participants Al Altomari - Chairman and CEO Scott Coiante - CFO Amy Welsh - Chief Commercial Off...

2023-08-09 08:14:47 ET Agile Therapeutics press release ( NASDAQ: AGRX ): Q2 Non-GAAP EPS of -$3.10 beats by $1.85 . Revenue of $5.5M (+158.2% Y/Y) beats by $0.87M . Twirla Demand and Factory Sales Up 24% and 42% Respectively in Second Quarter 2023 Compared to ...